✦ LIBER ✦

Effective treatment of active Crohn's disease with humanized monoclonal antibody MRA to interleukin-6 receptor: A randomized placebo-controlled trial

✍ Scribed by Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; Akira Andoh; Takayuki Matsumoto; Takehira Yamamura; Junichi Azuma; Norihiro Nishimoto; Kazuyuki Yoshizaki; Takashi Shimoyama; Tadamitsu Kishimoto

Book ID: 119426983
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 103 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(03)80123-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized Placebo-Controlled Trial of

A Randomized Placebo-Controlled Trial of a Humanized Monoclonal Antibody to α4 Integrin in Active Crohn's Disease

✍ Fiona H. Gordon; Clement W.Y. Lai; Mark I. Hamilton; Miles C. Allison; Emmanuel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 245 KB

A pilot randomized trial of a human anti

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease

✍ Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 249 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

✍ William J. Sandborn; Brian Feagan; Graham Radford-Smith; Agota Kovacs; Robert En 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Treatment of rheumatoid arthritis with h

Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

✍ Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 3 views

## Abstract ## Objective Interleukin‐6 (IL‐6) is a pleiotropic cytokine that regulates the immune response, inflammation, and hematopoiesis. Overproduction of IL‐6 plays pathologic roles in rheumatoid arthritis (RA), and the blockade of IL‐6 may be therapeutically effective for the disease. This s

A randomized controlled trial of CDP571,

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB